{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:40:44Z","timestamp":1765438844045,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.prnil.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T22:38:20Z","timestamp":1668206300000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Detection of recurrence sites using 18F-fluorocholine PET\/CT in prostate cancer patients with PSA failure"],"prefix":"10.1016","volume":"11","author":[{"given":"Dong-Yun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo Sung","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Kyu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Soo","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5348-9178","authenticated-orcid":false,"given":"Jae-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prnil.2022.11.001_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.prnil.2015.06.003","article-title":"Epidemiology of prostate cancer in South Korea","volume":"3","author":"Han","year":"2015","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2022.11.001_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3349\/ymj.2019.60.3.257","article-title":"Trends in prostate cancer prevalence and radical prostatectomy rate according to age structural changes in South Korea between 2005 and 2015","volume":"60","author":"Lee","year":"2019","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.prnil.2022.11.001_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.prnil.2020.06.002","article-title":"Impact of the evolving United States Preventative Services Task Force policy statements on incidence and distribution of prostate cancer over 15 years in a statewide cancer registry","volume":"9","author":"Jeong","year":"2021","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2022.11.001_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1148\/rg.2019180079","article-title":"Revisiting prostate cancer recurrence with PSMA PET: Atlas of typical and atypical patterns of spread","volume":"39","author":"Barbosa","year":"2019","journal-title":"Radiographics"},{"key":"10.1016\/j.prnil.2022.11.001_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00432-019-03085-w","article-title":"Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer","volume":"146","author":"Choi","year":"2020","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.prnil.2022.11.001_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12149-012-0601-8","article-title":"Detection of recurrent prostate cancer with 18F-fluorocholine PET\/CT in relation to PSA level at the time of imaging","volume":"26","author":"Kwee","year":"2012","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.prnil.2022.11.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756287218815793","article-title":"Detection rates of recurrent prostate cancer: 68 Gallium (Ga)-labelled prostate-specific membrane antigen versus choline PET\/CT scans. A systematic review","volume":"11","author":"Moghul","year":"2019","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.prnil.2022.11.001_bib8","first-page":"2.e1","article-title":"\u201cReal-world\u201d evaluation of 18F-Choline PET\/CT practices in prostate cancer patients and impact on changes in therapeutic strategy","volume":"38","author":"Niziers","year":"2020","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.prnil.2022.11.001_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/RLU.0000000000003125","article-title":"10-year clinical experience with 18F-choline PET\/CT: An Italian multicenter retrospective assessment of 3343 patients","volume":"45","author":"Zattoni","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.prnil.2022.11.001_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.prnil.2022.05.001","article-title":"Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy","volume":"10","author":"Kim","year":"2022","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2022.11.001_bib11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0006-291X(02)00920-8","article-title":"Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers","volume":"296","author":"Ram\u00edrez de Molina","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.prnil.2022.11.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0191487","article-title":"18F-fluorocholine PET\/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study","volume":"13","author":"Gillebert","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.prnil.2022.11.001_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.prnil.2019.01.002","article-title":"18F-Fluoromethylcholine-positron emission tomography\/computed tomography for diagnosing bone and lymph node metastases in patients with intermediate- or high-risk prostate cancer","volume":"7","author":"Mortensen","year":"2019","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2022.11.001_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijrobp.2016.07.009","article-title":"Posttreatment prostate-specific antigen 6 months after radiation with androgen deprivation therapy predicts for distant metastasis\u2013free survival and prostate cancer\u2013specific mortality","volume":"96","author":"Naik","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prnil.2022.11.001_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.euo.2021.01.001","article-title":"Management of persistently elevated prostate-specific antigen after radical prostatectomy: a systematic review of the literature","volume":"4","author":"Ploussard","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.prnil.2022.11.001_bib16","series-title":"Prostate-Cancer-2017-pocket.pdf","first-page":"49","author":"Bolla","year":"2017"},{"key":"10.1016\/j.prnil.2022.11.001_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RLU.0b013e3182867f3c","article-title":"Choline PET or PET\/CT and biochemical relapse of prostate cancer: A systematic review and meta-analysis","volume":"38","author":"Evangelista","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.prnil.2022.11.001_bib18","first-page":"906","article-title":"A\u00a0model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy","volume":"179","author":"Choueiri","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.prnil.2022.11.001_bib19","article-title":"Clinical PET imaging in prostate cancer\u2014Erratum","volume":"37","author":"Tam","year":"2017","journal-title":"Radiographics"},{"key":"10.1016\/j.prnil.2022.11.001_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00259-007-0581-4","article-title":"The detection rate of [11C]Choline-PET\/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer","volume":"35","author":"Krause","year":"2008","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.prnil.2022.11.001_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00259-009-1253-3","article-title":"Predictive factors of [11C]choline PET\/CT in patients with biochemical failure after radical prostatectomy","volume":"37","author":"Giovacchini","year":"2010","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.prnil.2022.11.001_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2967\/jnumed.120.252528","article-title":"Biochemical persistence of prostate-specific antigen after robot-assisted laparoscopic radical prostatectomy: tumor localizations using PSMA PET\/CT imaging","volume":"62","author":"Meijer","year":"2021","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.prnil.2022.11.001_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4320178","article-title":"Detection rate of 18F-fluorethylcholine-PET\/CT in relation to PSA Value in PCA patients referred with biochemical relapse","volume":"2020","author":"Takesh","year":"2020","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.prnil.2022.11.001_bib24","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2967\/jnumed.115.160382","article-title":"Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET\/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy","volume":"56","author":"Morigi","year":"2015","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.prnil.2022.11.001_bib25","article-title":"The diagnostic role of 18F-choline, 18F-fluciclovine and 18F-PSMA PET\/CT in the detection of prostate cancer with biochemical recurrence: a meta-analysis","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.prnil.2022.11.001_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12082153","article-title":"Diagnostic performance of pet imaging using different radiopharmaceuticals in prostate cancer according to published meta-analyses","volume":"12","author":"Annunziata","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prnil.2022.11.001_bib27","first-page":"1","article-title":"Outcome after 68ga-psma-11 versus choline pet-based salvage radiotherapy in patients with biochemical recurrence of prostate cancer: A matched-pair analysis","volume":"12","author":"Hegemann","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prnil.2022.11.001_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.prnil.2022.04.003","article-title":"Diagnostic accuracy of F-18-Fluorocholine PET\/CT and multiparametric MRI for prostate cancer","volume":"10","author":"Kim","year":"2022","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2022.11.001_bib29","first-page":"437","article-title":"Usefulness of 18F-choline positron emission tomography-computed tomography in the therapeutic management of patients with biochemical recurrence of prostate adenocarcinoma treated with brachytherapy","volume":"44","author":"L\u00f3pez Rodr\u00edguez","year":"2020","journal-title":"Actas Urol\u00f3gicas Espa\u00f1olas (English Ed"},{"key":"10.1016\/j.prnil.2022.11.001_bib30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12020-018-01832-6","article-title":"18F-choline PET\/CT incidental thyroid uptake in patients studied for prostate cancer","volume":"63","author":"Albano","year":"2019","journal-title":"Endocrine"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888222000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888222000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:01:48Z","timestamp":1762419708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888222000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2287888222000642"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2022.11.001","relation":{},"ISSN":["2287-8882"],"issn-type":[{"type":"print","value":"2287-8882"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of recurrence sites using 18F-fluorocholine PET\/CT in prostate cancer patients with PSA failure","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}